Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yebio is a China-based animal health company focused on the research, development, manufacturing, sales, service, and international trade of veterinary biological products. The company is best known for poultry, swine, duck, and companion-animal vaccines, along with diagnostic reagents used for animal disease prevention, diagnosis, and treatment. Its portfolio includes commercialized inactivated, live, recombinant, reverse-genetics, and subunit vaccines targeting major livestock and poultry pathogens. Yebio also emphasizes industrial-scale vaccine production and operates an animal vaccine intelligent manufacturing platform supported by in-house R&D capabilities, including a state key laboratory in animal genetic engineering vaccines. The company appears to be an established commercial-stage veterinary vaccine manufacturer rather than a human therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yebio.